Dupilumab ELISA Kit (DB732018)

Fiche technique Partager le produit Copier les informations

Aperçu
Images
Reférences
Fiche technique
SDS

Aperçu

Numéro de catalogue	DB732018
Description	Dupilumab ELISA Kit (DB732018) — Quantitative competitive ELISA for Dupilumab. Sample: Plasma, Serum. Range: 78.125 ng/mL - 5, 000 ng/mL. Highlights ●Competitive Format — High specificity, reliable quantification. ●Ready-to-Use — Complete kit with pre-coated plates included.
Type d'échantillon	Plasma, Serum
Sensibilité	48.20 ng/ml
Plage	78.13-5,000 ng/ml
Numéro d'accès	P24394
Applications	ELISA
Méthode de détection	Colorimetric
Type de test	Quantitative
Retraitement	90-120%
Expédition	2-8 ℃
Stabilité et stockage	When the kit was stored at the recommended temperature for 6 months, the signal intensity decreased by less than 20%. For unopened kits, if you want to prolong the storage time, please store the Standard, Detection A, Detection B and Microplate at - 20℃, the rest reagents should be store at 4℃.
Spécifications	Dupilumab
Noms alternatifs	CD124, REGN668, SAR231893, 1190264-60-8
Contexte	Interleukin-4 receptor subunit alpha (Dupilumab) is a ~89 kDa protein. Receptor for both interleukin 4 and interleukin 13. Couples to the JAK1/2/3-STAT6 pathway. The IL4 response is involved in promoting Th2 differentiation. The IL4/IL13 responses are involved in regulating IgE production and, chemokine and mucus production at sites of allergic inflammation. In certain cell types, can signal through activation of insulin receptor substrates, IRS1/IRS2. 1. Andrews, AL. et al. (2006) The Journal of allergy and clinical immunology 118, 858-65. PMID: 17030238
Note	For Research Use Only.